How Tumors Affect Hemodynamics: A Diffusion Study on the Zebrafish Transplantable Model of Medullary Thyroid Carcinoma by Selective Plane Illumination Microscopy
- PMID: 39769158
- PMCID: PMC11678154
- DOI: 10.3390/ijms252413392
How Tumors Affect Hemodynamics: A Diffusion Study on the Zebrafish Transplantable Model of Medullary Thyroid Carcinoma by Selective Plane Illumination Microscopy
Abstract
Medullary thyroid carcinoma (MTC), a rare neuroendocrine tumor comprising 3-5% of thyroid cancers, arises from calcitonin-producing parafollicular C cells. Despite aggressive behavior, surgery remains the primary curative treatment, with limited efficacy reported for radiotherapy and chemotherapy. Recent efforts have explored the pathogenetic mechanisms of MTC, identifying it as a highly vascularized neoplasm overexpressing pro-angiogenic factors. Building on the established benefits of zebrafish embryos, we previously created an in vivo MTC xenograft platform that allows real-time observation of tumor-induced angiogenesis and evaluation of the anti-angiogenic effects of tyrosine kinase inhibitors. In this study, we present a method using selective plane illumination microscopy (SPIM) to characterize vascular permeability in these xenografted embryos. Taking advantage of dextran injections into the blood flow of zebrafish embryos, we found that the diffusion coefficient in embryos grafted with MTC cells was about tenfold lower compared with the same parameter in controls. The results demonstrate the potential of our approach to estimate diffusion parameters, providing valuable insights into vascular permeability changes in MTC-implanted zebrafish embryos compared with controls. Our study sheds light on the intricate vascular biology of MTC, offering a promising tool for future investigations into tumor-induced angiogenesis and therapeutic strategies in diverse neoplasms.
Keywords: medullary thyroid carcinoma (MTC); selective plane illumination microscopy (SPIM); tumor xenograft; vascular permeability; zebrafish.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures













Similar articles
-
Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model.Int J Mol Sci. 2021 Mar 16;22(6):3031. doi: 10.3390/ijms22063031. Int J Mol Sci. 2021. PMID: 33809722 Free PMC article.
-
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.Mol Cell Endocrinol. 2019 Sep 15;495:110519. doi: 10.1016/j.mce.2019.110519. Epub 2019 Jul 25. Mol Cell Endocrinol. 2019. PMID: 31352037
-
A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis.Endocr Relat Cancer. 2007 Jun;14(2):433-44. doi: 10.1677/ERC-06-0033. Endocr Relat Cancer. 2007. PMID: 17639056
-
Update on Targeted Therapy in Medullary Thyroid Cancer.Front Endocrinol (Lausanne). 2021 Aug 19;12:708949. doi: 10.3389/fendo.2021.708949. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34489865 Free PMC article. Review.
-
Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma.Endocr Pathol. 2023 Mar;34(1):1-22. doi: 10.1007/s12022-023-09753-5. Epub 2023 Mar 8. Endocr Pathol. 2023. PMID: 36890425 Review.
References
-
- Modigliani E., Cohen R., Campos J.M., Conte-Devolx B., Maes B., Boneu A., Schlumberger M., Bigorgne J.C., Dumontier P., Leclerc L., et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: Results in 899 patients. The GETC Study Group. Groupe d’etude des tumeurs a calcitonine. Clin. Endocrinol. 1998;48:265–273. doi: 10.1046/j.1365-2265.1998.00392.x. - DOI - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases